CircRNA_101951 promotes migration and invasion of colorectal cancer cells by regulating the KIF3A‑mediated EMT pathway

Li,Yue‑Feng; Pei,Fu‑Lai; Cao,Ming‑Zheng

doi:10.3892/etm.2020.8600

CircRNA_101951 promotes migration and invasion of colorectal cancer cells by regulating the KIF3A‑mediated EMT pathway

Authors:
- Yue‑Feng Li
- Fu‑Lai Pei
- Ming‑Zheng Cao
View Affiliations

Affiliations: Department of Oncology, Linyi Central Hospital, Linyi, Shandong 276400, P.R. China, Department of General Surgery, Linyi Central Hospital, Linyi, Shandong 276400, P.R. China
Published online on: March 12, 2020 https://doi.org/10.3892/etm.2020.8600
Pages: 3355-3361
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer (CRC) is one of the most lethal tumor types worldwide. Circular RNAs (circRNAs), which are covalent closed loops of RNA, perform vital roles for the proliferation and metastasis of a variety of tumor types. In the present study, the expression, function and molecular mechanisms of action of a novel circRNA, circRNA_101951, were examined in CRC. The expression levels of circRNA_101951 in CRC tissue and cell lines were examined using reverse transcription‑quantitative (RT‑qPCR). Cell proliferation, the clone formation ability, cell apoptosis, the cell cycle and the cell migratory and invasive abilities were examined using MTT assays, colony formation assays, flow cytometric assays, and cell migration and invasion assays, respectively. The effects of circRNA_101951 on Kinesin II family member 3A (KIF3A) related gene expression were examined using RT‑qPCR and western blot assays. The results indicated that circRNA_101951 was increased in CRC tissues and cell lines. The downregulation of circRNA_101951 inhibited cell proliferation and colony formation as well as cell migration and invasion of CRC cell lines. In addition, the downregulation of circRNA_101951 blocked the KIF3A‑mediated epithelial‑mesenchymal transition (EMT) pathway, which was detected by examining the expression levels of KIF3A and EMT related proteins. In conclusion, the current data revealed that circRNA_101951 may act as a potential biomarker for patients with CRC, and provided a novel insight demonstrating that the suppression of circRNA_101951 may be a potential therapeutic strategy for CRC.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018.PubMed/NCBI View Article : Google Scholar
2	Bopanna S, Ananthakrishnan AN, Kedia S, Yajnik V and Ahuja V: Risk of colorectal cancer in Asian patients with ulcerative colitis: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2:269–276. 2017.PubMed/NCBI View Article : Google Scholar
3	Longo WE, Virgo KS, Johnson FE, Oprian CA, Vernava AM, Wade TP, Phelan MA, Henderson WG, Daley J and Khuri SF: Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum. 43:83–91. 2000.PubMed/NCBI View Article : Google Scholar
4	Kube R, Mroczkowski P, Granowski D, Benedix F, Sahm M, Schmidt U, Gastinger I and Lippert H: Study group Qualitätssicherung Kolon/Rektum-Karzinome (Primärtumor) (Quality assurance in primary colorectal carcinoma): Anastomotic leakage after colon cancer surgery: A predictor of significant morbidity and hospital mortality, and diminished tumour-free survival. Eur J Surg Oncol. 36:120–124. 2010.PubMed/NCBI View Article : Google Scholar
5	Qu S, Yang X, Li X, Wang J, Gao Y, Shang R, Sun W, Dou K and Li H: Circular RNA: A new star of noncoding RNAs. Cancer Lett. 365:141–148. 2015.PubMed/NCBI View Article : Google Scholar
6	Zhang HD, Jiang LH, Hou JC, Zhong SL, Zhou SY, Zhu LP, Li J, Wang DD, Sun DW, Ji ZL and Tang JH: Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer. Biomed Pharmacother. 107:1342–1353. 2018.PubMed/NCBI View Article : Google Scholar
7	Zhang M, Xia B, Xu Y, Zhang Y, Xu J and Lou G: Circular RNA (hsa_circ_0051240) promotes cell proliferation, migration and invasion in ovarian cancer through miR-637/KLK4 axis. Artif Cells Nanomed Biotechnol. 47:1224–1233. 2019.PubMed/NCBI View Article : Google Scholar
8	Zhang XL, Xu LL and Wang F: Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR-138 targets TERT and PD-L1. Cell Biol Int. 41:1056–1064. 2017.PubMed/NCBI View Article : Google Scholar
9	Zhang Y, Liang W, Zhang P, Chen J, Qian H, Zhang X and Xu W: Circular RNAs: Emerging cancer biomarkers and targets. J Exp Clin Cancer Res. 36(152)2017.PubMed/NCBI View Article : Google Scholar
10	Zhang Z, Xie Q, He D, Ling Y, Li Y, Li J and Zhang H: Circular RNA: New star, new hope in cancer. BMC Cancer. 18(834)2018.PubMed/NCBI View Article : Google Scholar
11	Cortes-Lopez M and Miura P: Emerging functions of circular RNAs. Yale J Biol Med. 89:527–537. 2016.PubMed/NCBI
12	Han YN, Xia SQ, Zhang YY, Zheng JH and Li W: Circular RNAs: A novel type of biomarker and genetic tools in cancer. Oncotarget. 8:64551–64563. 2017.PubMed/NCBI View Article : Google Scholar
13	Sun H, Tang W, Rong D, Jin H, Fu K, Zhang W, Liu Z, Cao H and Cao X: Hsa_circ_0000520, a potential new circular RNA biomarker, is involved in gastric carcinoma. Cancer Biomark. 21:299–306. 2018.PubMed/NCBI View Article : Google Scholar
14	Shang X, Li G, Liu H, Li T, Liu J, Zhao Q and Wang C: Comprehensive circular RNA profiling reveals that hsa_circ_0005075, a new circular RNA biomarker, is involved in hepatocellular crcinoma development. Medicine (Baltimore). 95(e3811)2016.PubMed/NCBI View Article : Google Scholar
15	Zhu X, Wang X, Wei S, Chen Y, Chen Y, Fan X, Han S and Wu G: hsa_circ_0013958: A circular RNA and potential novel biomarker for lung adenocarcinoma. FEBS J. 284:2170–2182. 2017.PubMed/NCBI View Article : Google Scholar
16	Liu T, Liu S, Xu Y, Shu R, Wang F, Chen C, Zeng Y and Luo H: Circular RNA-ZFR inhibited cell proliferation and promoted apoptosis in gastric cancer by sponging miR-130a/miR-107 and Modulating PTEN. Cancer Res Treat. 50:1396–417. 2018.PubMed/NCBI View Article : Google Scholar
17	Rong D, Lu C, Zhang B, Fu K, Zhao S, Tang W and Cao H: CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p. Mol Cancer. 18(25)2019.PubMed/NCBI View Article : Google Scholar
18	Bai N, Peng E, Qiu X, Lyu N, Zhang Z, Tao Y, Li X and Wang Z: circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346. J Exp Clin Cancer Res. 37(172)2018.PubMed/NCBI View Article : Google Scholar
19	Greene FL, Stewart AK and Norton HJ: A new TNM staging strategy for node-positive (stage III) colon cancer: An analysis of 50,042 patients. Ann Surg. 236:416–421. 2002.PubMed/NCBI View Article : Google Scholar
20	Wang X, Zhu X, Zhang H, Wei S, Chen Y, Chen Y, Wang F, Fan X, Han S and Wu G: Increased circular RNA hsa_circ_0012673 acts as a sponge of miR-22 to promote lung adenocarcinoma proliferation. Biochem Biophys Res Commun. 496:1069–1075. 2018.PubMed/NCBI View Article : Google Scholar
21	Zhou LH, Yang YC, Zhang RY, Wang P, Pang MH and Liang LQ: CircRNA_0023642 promotes migration and invasion of gastric cancer cells by regulating EMT. Eur Rev Med Pharmacol Sci. 22:2297–2303. 2018.PubMed/NCBI View Article : Google Scholar
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
23	Xu XW, Zheng BA, Hu ZM, Qian ZY, Huang CJ, Liu XQ and Wu WD: Circular RNA hsa_circ_000984 promotes colon cancer growth and metastasis by sponging miR-106b. Oncotarget. 8:91674–91683. 2017.PubMed/NCBI View Article : Google Scholar
24	Liu Y, Lu C, Zhou Y, Zhang Z and Sun L: Circular RNA hsa_circ_0008039 promotes breast cancer cell proliferation and migration by regulating miR-432-5p/E2F3 axis. Biochem Biophys Res Commun. 502:358–363. 2018.PubMed/NCBI View Article : Google Scholar
25	Li J, Wang J, Chen Z, Chen Y and Jin M: Hsa_circ_0079530 promotes cell proliferation and invasion in non-small cell lung cancer. Gene. 665:1–5. 2018.PubMed/NCBI View Article : Google Scholar
26	Kun-Peng Z, Xiao-Long M and Chun-Lin Z: Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1. Int J Biol Sci. 14:321–330. 2018.PubMed/NCBI View Article : Google Scholar
27	Fu L, Chen Q, Yao T, Li T, Ying S, Hu Y and Guo J: Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma. Oncotarget. 8:43878–43888. 2017.PubMed/NCBI View Article : Google Scholar
28	Gao D, Qi X, Zhang X, Fang K, Guo Z and Li L: hsa_circRNA_0006528 as a competing endogenous RNA promotes human breast cancer progression by sponging miR-7-5p and activating the MAPK/ERK signaling pathway. Mol Carcinog. 58:554–564. 2019.PubMed/NCBI View Article : Google Scholar